Kerry Fenwick
Institute of Cancer Research(GB)Northumbria Healthcare NHS Foundation Trust(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy, Fibroblast Growth Factor Research, Glycosylation and Glycoproteins Research, Ovarian cancer diagnosis and treatment
Most-Cited Works
- → The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial(2018)656 cited
- → Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer(2015)554 cited
- → Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance(2018)438 cited
- → Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma(2011)397 cited
- → Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity(2013)363 cited
- → Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor(2012)334 cited